Mufg Americas Holdings Corp Xencor Inc Transaction History

Mufg Americas Holdings Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 07, 2018	SELL	$21.18 - $33.78 $4,151 - $6,620	-196 Reduced 29.39%	471 $14,000
Q4 2017 Feb 08, 2018	SELL	$19.29 - $24.83 $443 - $571	-23 Reduced 3.33%	667 $0
Q3 2017 Nov 13, 2017	SELL	$19.61 - $23.35 $1,686 - $2,008	-86 Reduced 11.08%	690 $0
Q2 2017 Aug 07, 2017	BUY	N/A	776	776 $0

215

71.5M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.42B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

Stay updated on Mufg Americas Holdings Corp with notifications on news.